1
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies. Medarex, Darby & Darby, January 10, 2006: US06984720 (70 worldwide citation)

The present invention provides human sequence antibodies against CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


2
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies and their uses. Medarex, Baker Botts, October 20, 2009: US07605238 (16 worldwide citation)

The present invention provides human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


3
Korman Alan J, Halk Edward L, Lonberg Nils, Keler Tibor P, Deo Yashwant M: Human ctla-4 antibodies and their uses. Medarex, June 6, 2007: EP1792991-A1 (13 worldwide citation)

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


4
Korman Alan J, Halk Edward L, Lonberg Nils, Keler Tibor P, Deo Yashwant M: Human ctla-4 antibodies and their uses. Medarex, June 12, 2002: EP1212422-A2 (6 worldwide citation)

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


5
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies and their uses. Medarex, Baker Botts L, September 13, 2011: US08017114 (4 worldwide citation)

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


6
Alan J Korman, Edward L Halk, Nils Lonberg, Yashwant M Deo, Tibor P Keler: Human CTLA-4 antibodies and their uses. Medarex, Baker Botts L, November 27, 2012: US08318916 (1 worldwide citation)

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


7
Korman Alan J, Halk Edward L, Lonberg Nils, Deo Yashwant M, Keler Tibor P: Human ctla-4 antibodies and their uses. Medarex, Korman Alan J, Halk Edward L, Lonberg Nils, Deo Yashwant M, Keler Tibor P, SERAFINI Andrew T, March 1, 2001: WO/2001/014424 (1 worldwide citation)

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


8
KORMAN ALAN J , HALK EDWARD L , LONBERG NILS , KELER TIBOR P , DEO YASHWANT M : [de] Humane Antikörper gegen CTLA-4-Antikörper und Verwendungen davon, [en] Human CTLA-4 antibodies and their uses, [fr] Anticorps CTLA-4 humains et leurs utilisations. E R SQUIBB & SONS L L C , January 28, 2015: EP2829609-A1

[en] The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.


9

10
Korman Alan J, Halk Edward L, Lonberg Nils, Deo Yashwant M, Keler Tibor P: Anticorps contre lantigene ctla-4 humain et utilisation, Human ctla-4 antibodies and their uses. Medarex, Medarex, ROBIC, March 1, 2001: CA2381770

The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.